<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Alpha Teknova Inc — News on 6ix</title>
<link>https://6ix.com/company/alpha-teknova-inc</link>
<description>Latest news and press releases for Alpha Teknova Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 20:01:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/alpha-teknova-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c9ce78dffbe2df11c74b.webp</url>
<title>Alpha Teknova Inc</title>
<link>https://6ix.com/company/alpha-teknova-inc</link>
</image>
<item>
<title>Teknova to Report First Quarter 2026 Financial Results on May 6, 2026</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-to-report-first-quarter-2026-financial-results-on-may-6-2026</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-to-report-first-quarter-2026-financial-results-on-may-6-2026</guid>
<pubDate>Wed, 22 Apr 2026 20:01:00 GMT</pubDate>
<description>HOLLISTER, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, following the close of market. Teknova will host a webcast and conference call on Wednesday, May 6, 2026, beg</description>
</item>
<item>
<title>Teknova Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Thu, 26 Feb 2026 05:00:00 GMT</pubDate>
<description>Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidanceFourth quarter 2025 total revenue was $10.0 million, up 8% over</description>
</item>
<item>
<title>Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-report-fourth-quarter-full-210100165</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-report-fourth-quarter-full-210100165</guid>
<pubDate>Thu, 05 Feb 2026 21:01:00 GMT</pubDate>
<description>HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026, following the close of market. Teknova will host a webcast and conference call on Thurs</description>
</item>
<item>
<title>Teknova Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-third-quarter-2025-210100999</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-third-quarter-2025-210100999</guid>
<pubDate>Thu, 06 Nov 2025 21:01:00 GMT</pubDate>
<description>Third quarter 2025 total revenue was $10.5 million, up 9% from prior yearAchieves five consecutive quarters of year-over-year revenue growthCompany reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results</description>
</item>
<item>
<title>Teknova to Report Third Quarter 2025 Financial Results on November 6, 2025</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-report-third-quarter-2025-200100152</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-report-third-quarter-2025-200100152</guid>
<pubDate>Tue, 28 Oct 2025 20:01:00 GMT</pubDate>
<description>HOLLISTER, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, following the close of market. Teknova will host a webcast and conference call on Thursday, November 6</description>
</item>
<item>
<title>Teknova Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-second-quarter-2025-200100182</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-second-quarter-2025-200100182</guid>
<pubDate>Thu, 07 Aug 2025 20:01:00 GMT</pubDate>
<description>Second quarter 2025 total revenue was $10.3 million, up 7% from prior yearAchieves four consecutive quarters of year-over-year revenue growthCompany reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial result</description>
</item>
<item>
<title>Teknova to Report Second Quarter 2025 Financial Results on August 7, 2025</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-report-second-quarter-2025-200500130</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-report-second-quarter-2025-200500130</guid>
<pubDate>Thu, 24 Jul 2025 20:05:00 GMT</pubDate>
<description>HOLLISTER, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2025, on Thursday, August 7, 2025, following the close of market. Teknova will host a webcast and conference call on Thursday, August 7, 2025,</description>
</item>
<item>
<title>Teknova Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-first-quarter-2025-200100124</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-first-quarter-2025-200100124</guid>
<pubDate>Thu, 08 May 2025 20:01:00 GMT</pubDate>
<description>First quarter 2025 total revenue was $9.8 million, up 5% from prior yearCompany introduced proprietary PluriFreeze™ cryopreservation system, in collaboration with Pluristyx, Inc.Company reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnosti</description>
</item>
<item>
<title>Teknova to Report First Quarter 2025 Financial Results on May 8, 2025</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-report-first-quarter-2025-235100684</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-report-first-quarter-2025-235100684</guid>
<pubDate>Thu, 24 Apr 2025 23:51:00 GMT</pubDate>
<description>HOLLISTER, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, following the close of market. Teknova will host a webcast and conference call on Thursday, May 8, 2025, begin</description>
</item>
<item>
<title>Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-pluristyx-launch-proprietary-plurifreeze-120000734</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-pluristyx-launch-proprietary-plurifreeze-120000734</guid>
<pubDate>Wed, 19 Mar 2025 12:00:00 GMT</pubDate>
<description>Innovative product line is purpose-built to streamline the manufacture of allogeneic cell therapies. Available exclusively from Teknova starting today.HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s PluriFreeze™ cryopreservation system is available for purchase exclusively from Teknova. Teknova is a leading producer of critical reagents for the discovery, development, and commercialization</description>
</item>
<item>
<title>Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-pluristyx-announce-collaboration-streamline-230000697</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-pluristyx-announce-collaboration-streamline-230000697</guid>
<pubDate>Tue, 11 Mar 2025 23:00:00 GMT</pubDate>
<description>Teknova to Become the Exclusive Manufacturer and Distributor of Pluristyx’s Novel PluriFreeze™ Cryopreservation SystemHOLLISTER, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that the companies are collaborating to produce and commercialize Pluristyx's PluriFreeze™ product line, a cryopreservative and cell wash media system intended for use by customers who are developing next generation allogeneic cell therapies.</description>
</item>
<item>
<title>Teknova Reports Fourth Quarter and Full Year 2024 Financial Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-fourth-quarter-full-210500172</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-fourth-quarter-full-210500172</guid>
<pubDate>Tue, 04 Mar 2025 21:05:00 GMT</pubDate>
<description>Full year 2024 total revenue was $37.7 million, up 3% year-over-year and in line with guidanceFourth quarter 2024 total revenue was $9.3 million, up 18% over the same quarter prior yearCompany provides 2025 revenue guidance of $39-42 million HOLLISTER, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular d</description>
</item>
<item>
<title>Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-report-fourth-quarter-full-210500502</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-report-fourth-quarter-full-210500502</guid>
<pubDate>Thu, 20 Feb 2025 21:05:00 GMT</pubDate>
<description>HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2024, on Tuesday, March 4, 2025, following the close of market. Teknova will host a webcast and conference call on Tuesday, M</description>
</item>
<item>
<title>Teknova Reports Third Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-third-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-third-quarter-2024-financial-results</guid>
<pubDate>Thu, 07 Nov 2024 05:00:00 GMT</pubDate>
<description>Third quarter 2024 total revenue was $9.6 million, up 17% over the same quarter prior yearCompany lowers 2024 total free cash outflow outlook to less than $16</description>
</item>
<item>
<title>Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-to-report-third-quarter-2024-financial-results-on-november-7-2024</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-to-report-third-quarter-2024-financial-results-on-november-7-2024</guid>
<pubDate>Thu, 24 Oct 2024 04:00:00 GMT</pubDate>
<description>HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the</description>
</item>
<item>
<title>Teknova Reports Second Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-second-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-reports-second-quarter-2024-financial-results</guid>
<pubDate>Tue, 13 Aug 2024 04:00:00 GMT</pubDate>
<description>Second quarter 2024 total revenue was $9.6 million, up 3% sequentiallyRaised $15.4 million of equity capital in July 2024Launched two new offerings:</description>
</item>
<item>
<title>Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-introduces-proprietary-express-teksm-production-service-and-expanded-manufacturing-grade-options-to-expedite-novel-therapy-development</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-introduces-proprietary-express-teksm-production-service-and-expanded-manufacturing-grade-options-to-expedite-novel-therapy-development</guid>
<pubDate>Tue, 13 Aug 2024 04:00:00 GMT</pubDate>
<description>Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New</description>
</item>
<item>
<title>Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-to-report-second-quarter-2024-financial-results-on-august-13-2024</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-to-report-second-quarter-2024-financial-results-on-august-13-2024</guid>
<pubDate>Tue, 30 Jul 2024 04:00:00 GMT</pubDate>
<description>HOLLISTER, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the</description>
</item>
<item>
<title>Teknova Announces $15.4 Million Private Placement</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-announces-dollar154-million-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-announces-dollar154-million-private-placement</guid>
<pubDate>Fri, 12 Jul 2024 04:00:00 GMT</pubDate>
<description>HOLLISTER, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the</description>
</item>
<item>
<title>Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results</title>
<link>https://6ix.com/company/alpha-teknova-inc/news/teknova-provides-strategic-business-update-and-announces-preliminary-second-quarter-2024-results</link>
<guid isPermaLink="true">https://6ix.com/company/alpha-teknova-inc/news/teknova-provides-strategic-business-update-and-announces-preliminary-second-quarter-2024-results</guid>
<pubDate>Tue, 09 Jul 2024 04:00:00 GMT</pubDate>
<description>Second quarter 2024 total revenue is in the range of $9.4 to $9.6 million Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., July</description>
</item>
</channel>
</rss>